Skip to Content

93 Results Found

  • Article
  • Open Access
9 Citations
3,637 Views
14 Pages

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus

  • Young Chan Kim,
  • Arlen-Celina Lücke,
  • César López-Camacho,
  • Beate Mareike Kümmerer and
  • Arturo Reyes-Sandoval

Mayaro virus (MAYV) is an emerging alphavirus causing acute febrile illness associated with chronic polyarthralgia. Although MAYV is currently restricted to tropical regions in South America around the Amazon basin, it has the potential to spread glo...

(This article belongs to the Special Issue Antivirals and Vaccines)
  • Article
  • Open Access
3 Citations
4,012 Views
18 Pages

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents

  • Naomi S. Coombes,
  • Kevin R. Bewley,
  • Yann Le Duff,
  • Matthew Hurley and ,
  • Lauren J. Smith,
  • Thomas M. Weldon,
  • Karen Osman,
  • Steven Pullan,
  • Neil Berry and
  • Simon G. P. Funnell
  • + 8 authors+ 3 authors

25 February 2023

In the summer of 2020, it became clear that the genetic composition of SARS-CoV-2 was changing rapidly. This was highlighted by the rapid emergence of the D614G mutation at that time. In the autumn of 2020, the project entitled “Agility”...

(This article belongs to the Topic Host Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development)
  • Article
  • Open Access
13 Citations
5,998 Views
12 Pages

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay

  • Emma M. Bentley,
  • Samuel Richardson,
  • Mariliza Derveni,
  • Pramila Rijal and ,
  • Alain R. Townsend,
  • Jonathan L. Heeney,
  • Giada Mattiuzzo and
  • Edward Wright
  • + 3 authors+ 0 author

Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing. The use of pseudotype...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
2 Citations
4,092 Views
18 Pages

Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova

  • Mariana Ulinici,
  • Alen Suljič,
  • Monica Poggianella,
  • Rafaela Milan Bonotto and ,
  • Katarina Resman Rus,
  • Angela Paraschiv,
  • Amedeo Marco Bonetti,
  • Mihail Todiras,
  • Alexandru Corlateanu and
  • Alessandro Marcello
  • + 8 authors+ 3 authors

13 March 2023

The early availability of effective vaccines against SARS-CoV-2, the aetiologic cause of COVID-19, has been at the cornerstone of the global recovery from the pandemic. This study aimed to assess the antispike RBD IgG antibody titres and neutralisati...

(This article belongs to the Special Issue Antibody Response of Vaccines to SARS-CoV-2)
  • Article
  • Open Access
67 Citations
8,034 Views
18 Pages

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays

  • Inesa Hyseni,
  • Eleonora Molesti,
  • Linda Benincasa,
  • Pietro Piu and ,
  • Elisa Casa,
  • Nigel J Temperton,
  • Alessandro Manenti and
  • Emanuele Montomoli
  • + 3 authors+ 0 author

10 September 2020

The recent outbreak of a novel Coronavirus (SARS-CoV-2) and its rapid spread across the continents has generated an urgent need for assays to detect the neutralising activity of human sera or human monoclonal antibodies against SARS-CoV-2 spike prote...

(This article belongs to the Special Issue Antibody Responses to Viral Infections)
  • Article
  • Open Access
11 Citations
3,766 Views
8 Pages

Neutralising Antibodies against Enterovirus and Parechovirus in IVIG Reflect General Circulation: A Tool for Sero-Surveillance

  • Karen Couderé,
  • Karlijn van der Straten,
  • Lieke Brouwer,
  • Gerrit Koen and ,
  • Hetty van Eijk,
  • Dasja Pajkrt,
  • Jean-Luc Murk and
  • Katja C. Wolthers
  • + 3 authors+ 0 author

29 May 2021

Non-polio enteroviruses (NPEV) and parechoviruses (PeV) are widespread pathogens that cause significant morbidity. Surveillance is based on culturing or genotyping of virus strains found in clinical samples. Sero-surveillance, by measuring neutralisi...

(This article belongs to the Special Issue Surveillance for Polio and Non-polio Enteroviruses)
  • Article
  • Open Access
7 Citations
6,831 Views
8 Pages

15 December 2016

Pseudotyped viruses (PVs) produced by co-transfecting cells with plasmids expressing lentiviral core proteins and viral envelope proteins are potentially powerful tools for studying various aspects of equine influenza virus (EIV) biology. The aim of...

(This article belongs to the Special Issue Equine Influenza)
  • Article
  • Open Access
6 Citations
2,911 Views
11 Pages

Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients

  • Massimo Cugno,
  • Pier Luigi Meroni,
  • Dario Consonni,
  • Samantha Griffini and ,
  • Elena Grovetti,
  • Cristina Novembrino,
  • Adriana Torri,
  • Gloria Griffante,
  • Marisa Gariglio and
  • Flora Peyvandi
  • + 6 authors+ 1 author

The severity of coronavirus disease 2019 (COVID-19) may be influenced by pre-existing immune responses against endemic coronaviruses, but conflicting data have been reported. We studied 148 patients who were hospitalised because of a confirmed diagno...

(This article belongs to the Special Issue Advances in SARS-CoV-2 Infection)
  • Article
  • Open Access
8 Citations
5,417 Views
30 Pages

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

  • Polina Brangel,
  • Sina Tureli,
  • Barbara Mühlemann,
  • Nicole Liechti and ,
  • Daniel Zysset,
  • Olivier Engler,
  • Isabel Hunger-Glaser,
  • Ioana Ghiga,
  • Giada Mattiuzzo and
  • Lorenzo Subissi
  • + 51 authors+ 46 authors

18 December 2024

Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment of SARS-CoV-2 antigenicity....

(This article belongs to the Special Issue Host Cell-Virus Interaction, 4th Edition)
  • Article
  • Open Access
8 Citations
3,680 Views
11 Pages

Correlating IgG Levels with Neutralising Antibody Levels to Indicate Clinical Protection in Healthcare Workers at Risk during a Measles Outbreak

  • Siyuan Hu,
  • Nicola Logan,
  • Sarah Coleman,
  • Cariad Evans and ,
  • Brian J. Willett and
  • Margaret J. Hosie
  • + 1 author+ 0 author

4 August 2022

The rapid transmission of measles poses a great challenge for measles elimination. Thus, rapid testing is required to screen the health status in the population during measles outbreaks. A pseudotype-based virus neutralisation assay was used to measu...

(This article belongs to the Topic Infectious Diseases)
  • Brief Report
  • Open Access
30 Citations
3,175 Views
8 Pages

Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine

  • Kerri Basile,
  • Rebecca J. Rockett,
  • Kenneth McPhie,
  • Michael Fennell and ,
  • Jessica Johnson-Mackinnon,
  • Jessica E. Agius,
  • Winkie Fong,
  • Hossinur Rahman,
  • Danny Ko and
  • Jen Kok
  • + 14 authors+ 9 authors

13 September 2022

In late November 2021, the World Health Organization declared the SARS-CoV-2 lineage B.1.1.529 the fifth variant of concern, Omicron. This variant has acquired over 30 mutations in the spike protein (with 15 in the receptor-binding domain), raising c...

(This article belongs to the Section SARS-CoV-2 and COVID-19)
  • Article
  • Open Access
6 Citations
4,610 Views
11 Pages

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection

  • Rebecca Kinsley,
  • Stéphane Pronost,
  • Manuelle De Bock,
  • Nigel Temperton and ,
  • Janet M. Daly,
  • Romain Paillot and
  • Simon Scott
  • + 2 authors+ 0 author

21 August 2020

Equine influenza is a major respiratory disease of horses that is largely controlled by vaccination in some equine populations. Virus-neutralising antibodies, the mainstay of the protective immune response, are problematic in assaying for equine infl...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
1,120 Views
11 Pages

27 October 2025

Effective disinfectant validation is essential for ensuring biosafety in high-containment laboratories when lethal pathogens are being handled. Micro-Chem Plus™ (MCP) is widely used in high-containment facilities for pathogen disinfection and r...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
2 Citations
3,100 Views
21 Pages

Establishing the Kenya National Antivenom Quality Control Laboratory: Preclinical Efficacy Results of Four Antivenoms Against Venoms from the “Big Five” Snake Species in Kenya

  • Valentine Musabyimana,
  • John M. Kagira,
  • Jacob Lubuya,
  • Caroline W. Ngugi and ,
  • Brian M. Musau,
  • Wathuto Ogopotse,
  • Geoffrey Maranga,
  • Dennis Kotti,
  • Pamela M. Khasandi and
  • George O. Oluoch
  • + 11 authors+ 6 authors

19 February 2026

Antivenom administration is currently the only therapy for snakebite envenoming. However, in sub-Saharan Africa, inadequate quality control systems have led to deficits in the availability, accessibility, efficacy and safety of regionally available a...

(This article belongs to the Special Issue Venoms and Drugs)
  • Article
  • Open Access
8 Citations
3,069 Views
14 Pages

Over 32,000 individuals succumb to snake envenoming in sub-Saharan Africa (sSA) annually. This results from several factors, including a lack of antivenom products capable of neutralising the venoms of diverse snake species in this region. Most manuf...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
2 Citations
1,472 Views
14 Pages

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison

  • Laban Kato,
  • Jackson Sembera,
  • Gerald Kevin Oluka,
  • Joseph Ssebwana Katende and ,
  • Juliana Bemanzi,
  • Violet Ankunda,
  • Peter Ejou,
  • Ashwini Kurshan,
  • Carl Graham and
  • Jennifer Serwanga
  • + 10 authors+ 5 authors

21 March 2025

Background: The global SARS-CoV-2 pandemic revealed stark variability in clinical outcomes across populations, underscoring the need for region-tailored vaccination strategies. To inform standardised global immunisation efforts, this study compared l...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
4 Citations
3,888 Views
19 Pages

Specific Substitutions in Region V2 of gp120 env confer SHIV Neutralisation Resistance

  • Yalcin Pisil,
  • Zafer Yazici,
  • Hisatoshi Shida,
  • Shuzo Matsushita and
  • Tomoyuki Miura

A tier 2 SHIV-MK38 strain was obtained after two in vivo passages of tier 1 SHIV-MK1. SHIV-MK38#818, cloned from the MK38 strain, was neutralisation-resistant, like the parental MK38 strain, to SHIV-infected monkey plasma (MP), HIV-1-infected human p...

(This article belongs to the Section Viral Pathogens)
  • Article
  • Open Access
2 Citations
1,862 Views
17 Pages

Development of an Automated Cell-Based Assay for the Detection of the Functional Activity of Saxitoxin

  • Rachel Whiting,
  • Isobel Picken,
  • Grace Howells,
  • A. Christopher Green and ,
  • Chris Elliott and
  • Graeme C. Clark
  • + 1 author+ 0 author

29 April 2026

Saxitoxin (STX) is one of the most potent natural neurotoxins known and is the only marine toxin to be declared a chemical weapon. In both marine and freshwater systems filter feeding organisms can accumulate saxitoxin and human consumption of toxin-...

(This article belongs to the Special Issue Marine Biotoxins: Bioactivities, Identification, and Potential Bioprocesses)
  • Article
  • Open Access
7 Citations
4,300 Views
15 Pages

Neutralising Effects of Different Antibodies on Clostridioides difficile Toxins TcdA and TcdB in a Translational Approach

  • Georg Csukovich,
  • Nina Kramer,
  • Barbara Pratscher,
  • Ivana Gotic and ,
  • Patricia Freund,
  • Rainer Hahn,
  • Gottfried Himmler,
  • Sabine Brandt and
  • Iwan Anton Burgener
  • + 4 authors+ 0 author

15 February 2023

Given the high prevalence of intestinal disease in humans and animals, there is a strong need for clinically relevant models recapitulating gastrointestinal systems, ideally replacing in vivo models in accordance with the principles of the 3R. We est...

(This article belongs to the Special Issue Organoids: The New 3D-Frontier to Model Different Diseases In Vitro)
  • Article
  • Open Access
1,708 Views
17 Pages

Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine

  • Kerri Basile,
  • Jessica E. Agius,
  • Winkie Fong,
  • Kenneth McPhie and ,
  • Danny Ko,
  • Linda Hueston,
  • Connie Lam,
  • David Pham,
  • Sharon C.-A. Chen and
  • Rebecca J. Rockett
  • + 10 authors+ 5 authors

25 August 2025

We aimed to explore SARS-CoV-2 evolution during in vitro neutralisation using next generation sequencing, and to determine whether sera from individuals immunised with two doses of the Pfizer-BioNTech vaccine (BNT162b2) were as effective at neutralis...

(This article belongs to the Special Issue Emerging Concepts in SARS-CoV-2 Biology and Pathology 2.0)
  • Article
  • Open Access
6 Citations
1,824 Views
13 Pages

Neutralisation of the Immunoglobulin-Cleaving Activity of Streptococcus equi Subspecies equi IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine

  • Francesco Righetti,
  • Karina Hentrich,
  • Margareta Flock,
  • Sara Frosth and ,
  • Karin Jacobsson,
  • Joakim Bjerketorp,
  • Anuj Pathak,
  • Noela Ido,
  • Birgitta Henriques-Normark and
  • Andrew Stephen Waller
  • + 10 authors+ 5 authors

17 October 2025

Background: Streptococcus equi subspecies equi (S. equi) is the cause of strangles, one of the most prevalent diseases of horses worldwide. The disease is characterised by fever and the formation of abscesses in the lymph nodes of the head and n...

(This article belongs to the Special Issue Animal Diseases: Immune Response and Vaccines)
  • Article
  • Open Access
1 Citations
2,062 Views
11 Pages

23 November 2023

For coagulation to be initiated, anticoagulant glycosaminoglycans (GAGs) such as heparins need to be neutralised to allow fibrin clot formation. Platelet activation triggers the release of several proteins that bind GAGs, including histidine-rich gly...

(This article belongs to the Special Issue Heparin, Heparan Sulfate and Heparanase in Health and Disease)
  • Article
  • Open Access
27 Citations
4,866 Views
10 Pages

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

  • Gregory J. Walker,
  • Zin Naing,
  • Alberto Ospina Stella,
  • Malinna Yeang and ,
  • Joanna Caguicla,
  • Vidiya Ramachandran,
  • Sonia R. Isaacs,
  • David Agapiou,
  • Rowena A. Bull and
  • William D. Rawlinson
  • + 13 authors+ 8 authors

4 February 2021

Serological testing for SARS-CoV-2-specific antibodies provides important research and diagnostic information relating to COVID-19 prevalence, incidence and host immune response. A greater understanding of the relationship between functionally neutra...

(This article belongs to the Section SARS-CoV-2 and COVID-19)
  • Review
  • Open Access
24 Citations
8,928 Views
12 Pages

10 August 2018

Initial attempts to develop monoclonal antibodies as therapeutics to resolve influenza infections focused mainly on searching for antibodies with the potential to neutralise the virus in vitro with classical haemagglutination inhibition and microneut...

  • Brief Report
  • Open Access
6 Citations
4,406 Views
7 Pages

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia

  • Sean A. Lynch,
  • Kanta Subbarao,
  • Siddhartha Mahanty,
  • Bridget E. Barber and ,
  • Eileen V. Roulis,
  • Lia van der Hoek,
  • James S. McCarthy and
  • Kirsten M. Spann
  • + 3 authors+ 0 author

16 August 2021

The COVID-19 pandemic has highlighted the importance of understanding the immune response to seasonal human coronavirus (HCoV) infections such as HCoV-NL63, how existing neutralising antibodies to HCoV may modulate responses to SARS-CoV-2 infection,...

(This article belongs to the Collection Coronaviruses)
  • Article
  • Open Access
4 Citations
3,672 Views
15 Pages

The Application of Thermal Decomposition for Determination of Carbonate Acid-Neutralising Capacity for Improved Acid Mine Drainage Prediction

  • Andrea R. Gerson,
  • Paul Weber,
  • Roger St. C. Smart,
  • George Levay and ,
  • Mike Hutton-Ashkenny and
  • Rosalind Green
  • + 1 author+ 0 author

25 October 2021

This study developed an industry-applicable, thermal decomposition methodology for quantification of carbonate mineral acid neutralisation capacity (ANCtherm-carb) for waste rock, tailings, and other mined materials. Standard titration-based methods...

(This article belongs to the Section Mineral Processing and Extractive Metallurgy)
  • Communication
  • Open Access
5 Citations
5,161 Views
16 Pages

ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming

  • Stefanie K. Menzies,
  • Raquel Arinto-Garcia,
  • Fernanda Gobbi Amorim,
  • Iara Aimê Cardoso and ,
  • Camille Abada,
  • Thomas Crasset,
  • Fabien Durbesson,
  • Rebecca J. Edge,
  • Priscila El-Kazzi and
  • Christiane Schaffitzel
  • + 17 authors+ 12 authors

28 November 2023

Snakebite envenoming can be a life-threatening medical emergency that requires prompt medical intervention to neutralise the effects of venom toxins. Each year up to 138,000 people die from snakebites and threefold more victims suffer life-altering d...

(This article belongs to the Section Animal Venoms)
  • Article
  • Open Access
4 Citations
4,024 Views
15 Pages

Potential of a Bead-Based Multiplex Assay for SARS-CoV-2 Antibody Detection

  • Karla Rottmayer,
  • Mandy Schwarze,
  • Christian Jassoy,
  • Ralf Hoffmann and ,
  • Henry Loeffler-Wirth and
  • Claudia Lehmann
  • + 1 author+ 0 author

18 April 2024

Serological assays for SARS-CoV-2 play a pivotal role in the definition of whether patients are infected, the understanding of viral epidemiology, the screening of convalescent sera for therapeutic and prophylactic purposes, and in obtaining a better...

  • Article
  • Open Access
8 Citations
4,640 Views
13 Pages

Evidence of West Nile Virus Circulation in Horses and Dogs in Libya

  • Kholoud Khalid Ben-Mostafa,
  • Giovanni Savini,
  • Annapia Di Gennaro,
  • Liana Teodori and ,
  • Alessandra Leone,
  • Federica Monaco,
  • Mohammed Masoud A. Alaoqib,
  • Abdunnabi A. Rayes,
  • Abdunaser Dayhum and
  • Ibrahim Eldaghayes
  • + 5 authors+ 0 author

31 December 2023

West Nile virus (WNV) is a globally significant mosquito-borne Flavivirus that causes West Nile disease (WND). In Libya, evidence of WNV circulation has been reported in humans but never in animals. The aim of this study was to determine the seroprev...

(This article belongs to the Special Issue West Nile Virus and Other Zoonotic Infections)
  • Article
  • Open Access
5 Citations
4,105 Views
19 Pages

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants

  • Inge Pietersen,
  • Albertha van Zyl,
  • Edward Rybicki and
  • Inga Hitzeroth

28 November 2020

Vaccine efficacy requires the production of neutralising antibodies which offer protection against the native virus. The current gold standard for determining the presence of neutralising antibodies is the pseudovirion-based neutralisation assay (PBN...

(This article belongs to the Special Issue Bovine Papillomavirus Infection)
  • Article
  • Open Access
1 Citations
8,450 Views
14 Pages

19 January 2012

Lethal toxin (LT) of Bacillus anthracis reduces the production of a number of inflammatory mediators, including transcription factors, chemokines and cytokines in various human cell lines, leading to down-regulation of the host inflammatory response....

(This article belongs to the Special Issue Anthrax Toxin)
  • Article
  • Open Access
8 Citations
3,469 Views
10 Pages

Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay

  • Gary R. McLean,
  • Yueke Zhang,
  • Rene Ndoyi,
  • Adam Martin and
  • Julian Winer

15 December 2022

The quantification of neutralising antibodies (NAb) for SARS-CoV-2 has become an important tool for monitoring protective immunity following infection or immunisation. In this study, we evaluated using World-Health-Organisation-standard immunoglobuli...

(This article belongs to the Special Issue Detection of SARS-CoV-2 Neutralizing Antibodies and Vaccine Development)
  • Article
  • Open Access
1 Citations
1,178 Views
11 Pages

Robust Adaptive Immunity to MPXV in Older People Who Received Childhood Vaccinia Vaccination

  • Chris Davis,
  • Jianmin Zuo,
  • Rachel Bruton,
  • Marie Hodges and ,
  • Tom Roberts,
  • Maria Manali,
  • Paula Olmo,
  • Brian Willett,
  • Paul Moss and
  • Helen Parry
  • + 5 authors+ 0 author

26 January 2026

Monkeypox virus (MPXV) is a zoonotic Orthopoxvirus responsible for Monkeypox (Mpox), historically associated with sporadic zoonotic transmission but increasingly characterised by sustained human-to-human spread. While vaccinia-based vaccination is kn...

(This article belongs to the Section Infection Biology)
  • Article
  • Open Access
2 Citations
3,046 Views
16 Pages

Rehoming and Other Refinements and Replacement in Procedures Using Golden Hamsters in SARS-CoV-2 Vaccine Research

  • Malan Štrbenc,
  • Urška Kuhar,
  • Duško Lainšček,
  • Sara Orehek and ,
  • Brigita Slavec,
  • Uroš Krapež,
  • Tadej Malovrh and
  • Gregor Majdič
  • + 3 authors+ 0 author

14 August 2023

Effective vaccines are needed to fight the COVID-19 pandemic. Forty golden hamsters were inoculated with two promising vaccine candidates and eighteen animals were used in pilot trials with viral challenge. ELISA assays were performed to determine en...

(This article belongs to the Special Issue Implementing the 3Rs in Laboratory Animal Research—From Theory to Practice)
  • Review
  • Open Access
20 Citations
8,480 Views
18 Pages

31 January 2021

Serological assays detecting neutralising antibodies are important for determining the immune responses following infection or vaccination and are also often considered a correlate of protection. The target of neutralising antibodies is usually locat...

(This article belongs to the Special Issue Lentiviral Vectors)
  • Article
  • Open Access
4 Citations
4,486 Views
13 Pages

Avidity of Polyclonal Antibodies to Foot-and-Mouth Disease Virus in Bovine Serum Measured Using Bio-Layer Interferometry

  • Andrew E. Shaw,
  • Alison Burman,
  • Amin Asfor,
  • Emiliana Brocchi and ,
  • Santina Grazioli,
  • Clare Browning,
  • Anna Ludi,
  • Tobias J. Tuthill and
  • Donald P. King
  • + 4 authors+ 0 author

29 March 2022

Foot-and-mouth disease (FMD) is a disease of cloven-hoofed livestock caused by FMD virus (FMDV). FMD can be controlled through the use of inactivated vaccines, and it is well established that the protection afforded by FMD vaccines correlates strongl...

(This article belongs to the Special Issue Global Foot-and-Mouth Disease Control)
  • Article
  • Open Access
17 Citations
4,012 Views
9 Pages

Snakebite remains a significant public health burden globally, disproportionately affecting low-income and impoverished regions of the world. Recently, researchers have begun to focus on the use of small-molecule inhibitors as potential candidates fo...

(This article belongs to the Special Issue Natural Molecules in Drug Discovery and Pharmacology)
  • Article
  • Open Access
4 Citations
2,492 Views
12 Pages

Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients

  • Astrid I. Knell,
  • Anna K. Böhm,
  • Michael Jäger,
  • Julia Kerschbaum and ,
  • Sabine Engl,
  • Michael Rudnicki,
  • Lukas Buchwinkler,
  • Rosa Bellmann-Weiler,
  • Wilfried Posch and
  • Günter Weiss
  • + 5 authors+ 0 author

Patients with chronic kidney disease (CKD) or immunosuppression are at increased risk of severe SARS-CoV-2 infection. The vaccination of CKD patients has resulted in lower antibody concentrations and possibly reduced protection. However, little infor...

(This article belongs to the Section Public Health Microbiology)
  • Article
  • Open Access
4 Citations
3,345 Views
11 Pages

Detection and Serological Evidence of European Bat Lyssavirus 1 in Belgian Bats between 2016 and 2018

  • Inne Nauwelaers,
  • Claudia Van den Eynde,
  • Sanne Terryn,
  • Bob Vandendriessche and ,
  • Wout Willems,
  • Daan Dekeukeleire and
  • Steven Van Gucht
  • + 2 authors+ 0 author

Lyssaviruses are neurotropic viruses capable of inducing fatal encephalitis. While rabies virus has been successfully eradicated in Belgium, the prevalence of other lyssaviruses remains uncertain. In this study, we conducted a survey on live animals...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
1 Citations
1,760 Views
24 Pages

Characterisation of Naturally Occurring MERS-CoV Spike Mutations and Their Impact on Fusion and Neutralisation

  • Rachael Dempsey,
  • Hannah Goldswain,
  • Joseph Newman,
  • Nazia Thakur and ,
  • Tracy MacGill,
  • Todd Myers,
  • Robert Orr,
  • Dalan Bailey,
  • James P. Stewart and
  • Julian A. Hiscox
  • + 6 authors+ 1 author

18 March 2026

In this study, the phenotypic consequences of naturally occurring single nucleotide polymorphisms (SNPs) in the Middle East respiratory syndrome coronavirus (MERS-CoV) Spike protein were investigated. The impact of Spike mutations on the syncytia for...

(This article belongs to the Section Coronaviruses)
  • Article
  • Open Access
17 Citations
8,020 Views
17 Pages

The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India

  • Saurabh Attarde,
  • Ashwin Iyer,
  • Suyog Khochare,
  • Umesh Shaligram and ,
  • Mayur Vikharankar and
  • Kartik Sunagar
  • + 1 author+ 0 author

24 February 2022

Snake envenoming afflicts the Indian subcontinent with the highest rates of mortality (47,000) and morbidity globally. The only effective treatment for snakebites is the administration of antivenom, which is produced by the hyperimmunisation of equin...

  • Article
  • Open Access
1,288 Views
18 Pages

17 March 2026

Background: Porcine epidemic diarrhoea virus (PEDV) is a highly contagious pathogen causing severe diarrhoea and high mortality in neonatal piglets. Methods: In this study, consensus sequences encoding the N-terminal domain of spike subunit 1 (S1-NTD...

(This article belongs to the Special Issue Novel Insights into Porcine Viral Diseases: Recombinant Strains and Immune Responses)
  • Article
  • Open Access
11 Citations
4,433 Views
12 Pages

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

  • Naif Khalaf Alharbi,
  • Fahad Aljamaan,
  • Haya A. Aljami,
  • Mohammed W. Alenazi and ,
  • Hind Albalawi,
  • Abdulrahman Almasoud,
  • Fatima J. Alharthi,
  • Esam I. Azhar,
  • Tlili Barhoumi and
  • Anwar M. Hashem
  • + 7 authors+ 2 authors

17 August 2022

The Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic pathogen that can transmit from dromedary camels to humans, causing severe pneumonia, with a 35% mortality rate. Vaccine candidates have been developed and tested in mice, came...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
5 Citations
2,700 Views
16 Pages

Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort

  • Michael Schoefbaenker,
  • Rieke Neddermeyer,
  • Theresa Guenther,
  • Marlin M. Mueller and ,
  • Marie-Luise Romberg,
  • Nica Classen,
  • Marc T. Hennies,
  • Eike R. Hrincius,
  • Stephan Ludwig and
  • Eva U. Lorentzen
  • + 6 authors+ 1 author

8 December 2023

Virus-specific antibodies are crucial for protective immunity against SARS-CoV-2. Assessing functional antibodies through conventional or pseudotyped virus neutralisation tests (pVNT) requires high biosafety levels. Alternatively, the virus-free surr...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
8 Citations
5,928 Views
14 Pages

Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector

  • Lars Maurer,
  • Jihad El Andari,
  • Kleopatra Rapti,
  • Laura Spreyer and ,
  • Eike Steinmann,
  • Dirk Grimm and
  • Viet Loan Dao Thi
  • + 2 authors+ 0 author

27 January 2022

The hepatitis E virus (HEV) is a major global health problem, leading to large outbreaks in the developing world and chronic infections in the developed world. HEV is a non-enveloped virus, which circulates in the blood in a quasi-enveloped form. The...

(This article belongs to the Special Issue Novel Developments and Perspectives in Viral Vector Technology)
  • Article
  • Open Access
6 Citations
16,161 Views
17 Pages

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

  • Jonathan Kitonsa,
  • Jennifer Serwanga,
  • Hannah M. Cheeseman,
  • Andrew Abaasa and ,
  • Jane Frances Lunkuse,
  • Eugene Ruzagira,
  • Laban Kato,
  • Florence Nambaziira,
  • Gerald Kevin Oluka and
  • Pontiano Kaleebu
  • + 12 authors+ 7 authors

Background: The COVID-19 pandemic highlighted the need for innovative vaccine platforms that elicit durable immunity. Self-amplifying RNA (saRNA) vaccines offer rapid production and dose-sparing advantages over traditional mRNA platforms. In Uganda&r...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
11 Citations
5,477 Views
13 Pages

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules

  • Zheng Quan Toh,
  • Jennie Kosasih,
  • Fiona M. Russell,
  • Rita Reyburn and ,
  • James Fong,
  • Evelyn Tuivaga,
  • Felisita T. Ratu,
  • Cattram D. Nguyen,
  • Silivia Matanitobua and
  • Paul V. Licciardi
  • + 10 authors+ 5 authors

28 November 2019

The duration of cross-neutralising antibody responses (cross-NAb) following HPV immunisation is unknown. We compared cross-NAb responses in cohort of girls who were either unimmunised or had received immunisation with one, two or three doses of 4vHPV...

  • Review
  • Open Access
10 Citations
3,607 Views
24 Pages

Immune Response to MVA-BN Vaccination for Mpox: Current Evidence and Future Directions

  • Joanne Byrne,
  • Patrick D. M. C. Katoto,
  • Bruce Kirenga,
  • Wilber Sabiiti and ,
  • Andrew Obuku,
  • Virginie Gautier,
  • Patrick W. G. Mallon and
  • Eoin R. Feeney
  • + 3 authors+ 0 author

30 August 2025

The 2022 global mpox outbreak, caused by clade IIb of the monkeypox virus (MPXV), prompted emergency use authorisation of the Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN) vaccine, previously approved for smallpox prevention. Understanding...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Article
  • Open Access
1,559 Views
17 Pages

Subgenomic RNA and Limited Cross-Reactive Neutralising Antibodies Point to Potential Improvements in SARS-CoV-2 Clinical Handling

  • Carlos Davina-Nunez,
  • Sonia Perez-Castro,
  • Jorge Julio Cabrera-Alvargonzalez,
  • Elena Gonzalez-Alonso and ,
  • Sergio Silva-Bea,
  • Miriam Rodriguez-Perez,
  • Maria del Pilar Figueroa-Lamas,
  • Alexandre Perez-Gonzalez,
  • Victor del Campo and
  • Benito Regueiro-Garcia
  • + 7 authors+ 2 authors

The current clinical management of SARS-CoV-2 disease control and immunity may be not optimal anymore. Reverse transcription polymerase chain reaction (RT-PCR) of genomic viral RNA is broadly used for diagnosis, even though the virus may still be det...

(This article belongs to the Special Issue Viral Diseases of the Respiratory System—Molecular Mechanisms and Pathogenesis: 3rd Edition)
  • Article
  • Open Access
16 Citations
6,904 Views
11 Pages

Lagos Bat Virus Infection Dynamics in Free-Ranging Straw-Colored Fruit Bats (Eidolon helvum)

  • Richard D. Suu-Ire,
  • Anthony R. Fooks,
  • Ashley C. Banyard,
  • David Selden and ,
  • Kofi Amponsah-Mensah,
  • Silke Riesle,
  • Meyir Y. Ziekah,
  • Yaa Ntiamoa-Baidu,
  • James L. N. Wood and
  • Andrew A. Cunningham
  • + 5 authors+ 0 author

Bats are key species for ecological function, but they are also reservoirs of zoonotic agents, such as lyssaviruses that cause rabies. Little is known about the maintenance and transmission of lyssaviruses in bats, although the observation of clinica...

(This article belongs to the Special Issue Rabies Symptoms, Diagnosis, Prophylaxis and Treatment)

of 2